HomeAI · summaries
Storia in 7 fonti
GLP-1 Users May Experience A Surprising Lifesaving Benefit That Has Nothing To Do With Weight Loss
A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
GLP-1s demonstrate ‘large’ & ‘consistent’ protective effects against cancer metastases
CHICAGO — GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective study results presented at ASCO Annual…
- ·
medpagetoday.com
GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types
Accumulating evidence of possible benefit warrants randomized trials, experts say
- ·
lastampa.it
I farmaci anti-obesità potrebbero ridurre il rischio di metastasi in quattro tumori
Gli analoghi di Glp-1 sembrano prevenire la progressione delle neoplasie verso lo stadio metastatico nei pazienti diabetici. Lo rivela uno studio presentato du…
- ·
nbcnews.com
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis were less likely to progress to stage 4.
- ·
independent.co.uk
GLP-1 drugs may result in better outcomes for cancer patients, study claims
GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers
- ·
huffpost.com
GLP-1 Users May Experience A Surprising Lifesaving Benefit That Has Nothing To Do With Weight Loss
A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.
- ·
forbes.com
GLP-1 Weight Loss Drugs Could Stop Cancer Progressing Says New Study
GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several different types of tumors including breast and lung